Elizabeth Crane - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Elizabeth Crane's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Elizabeth Crane
Verified
Senior Copy Editor, Recode
San Francisco
Beats
Heritage ConservationInternational Relations Social Identity Fiction
Content
By Elizabeth Crane| Medium@ Elizabeth Crane·Follow4 min read·--Hello, Mr. President-Elect, or more realistically, hello to the weird, celebrity billionaire whispering this article seductively into your ear. By now, you’ve likely heard the news of South Korea’s President Yoon and his hilariously failed attempt at declaring martial law. For an aspiring autocrat, like yourself, this must have been a devastating blow. Imagine the nerve of his constituents fighting for their rights! Who do they think they are?
By Elizabeth Crane| Vox Verified In fall 2019, we launched our daily crossword puzzles on Vox, initially as an experiment. We wanted to see: Did our audience like solving crossword puzzles? Turns out, they absolutely did. Over the past few years, crossword puzzles quietly grew and became one of the most consistently popular pages on Vox.com.
By Elizabeth Crane| Medium@ Elizabeth Crane·Follow4 min read·--Hello, Mr. President-Elect, or more realistically, hello to the weird, celebrity billionaire whispering this article seductively into your ear. By now, you’ve likely heard the news of South Korea’s President Yoon and his hilariously failed attempt at declaring martial law. For an aspiring autocrat, like yourself, this must have been a devastating blow. Imagine the nerve of his constituents fighting for their rights! Who do they think they are?
Company Info
Recode
ReCode Therapeutics is a genetic medicines company based in Dallas, Texas, focused on developing targeted therapies for rare and common genetic diseases, particularly respiratory conditions like primary ciliary dyskinesia (PCD) and cystic fibrosis (CF). The company utilizes its proprietary SORT LNP (Selective ORgan Targeting Lipid Nanoparticle) platform to deliver mRNA and gene correction therapeutics directly to affected organs, addressing significant unmet medical needs. The SORT LNP platform allows for organ-specific delivery, enhancing the effectiveness of treatments by bypassing the liver when necessary. ReCode's pipeline includes mRNA therapies aimed at correcting the underlying genetic causes of PCD and CF, with plans to expand into other areas such as muscular, CNS, liver, infectious diseases, and oncology. The company emphasizes disease-modifying outcomes through its innovative approach to genetic medicine.
San Francisco, California, United States
+1 408-585-1700
Founded: 2014